Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-26T13:15:45.308Z Has data issue: false hasContentIssue false

How are we assessing functioning in schizophrenia? A need for a consensus approach

Published online by Cambridge University Press:  15 April 2020

J. Peuskens*
Affiliation:
Center K.U. Leuven, university Psychiatric, CampusKortenberg, Belgium
P. Gorwood
Affiliation:
Sainte-Anne Hospital (CMME), Paris Descartes University, Paris, France Inserm U894, centre of psychiatry and neuroscience, Sainte-Anne hospital, Paris, France
*
*Corresponding author. E-mail address:[email protected] (J. Peuskens).
Get access

Abstract

Efforts to improve everyday living skills are important in schizophrenia. What constitutes appropriate functioning is however difficult to evaluate. Several instruments were tested in different settings throughout Europe (EGOFORS initiative), including two new questionnaires (FROGS, PSRS), to provide directions on domains to be assessed and tools to be used.

Type
Short communication
Copyright
Copyright © Elsevier Masson SAS 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Amador, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psych. 1994; 51: 826836.CrossRefGoogle ScholarPubMed
American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ednWashington DC: American Psychiatric Association; 1994.Google Scholar
Andreasen, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005; 162: 441449.CrossRefGoogle ScholarPubMed
Barak, Y., Bleich, A., Aizenberg, D.Psychosocial remission in schizophrenia: developing a clinician-rated scale. Compr Psychiatry. 51 1: 2010 9498.CrossRefGoogle ScholarPubMed
Barak, et al. Psychosocial remission in schizophrenia; developing a clinician rated scale. Med Psychiatry. 2008; 7: 4647.Google Scholar
Birchwood, et al. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990; 157: 853859.CrossRefGoogle ScholarPubMed
Bodlund, et al. Axis V. Global Assessment of Functioning Scale Evaluation of a self-report version. Acta Psychiatr Scand. 1994; 90: 342347.CrossRefGoogle ScholarPubMed
Burns, Patrick, Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand. 2007; 116: 403418.CrossRefGoogle ScholarPubMed
Davidson, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results from a 6-week, randomized, placebo-controlled study. Schizophr Res. 2007; 93: 117130.CrossRefGoogle ScholarPubMed
Hall, Global Assessment of Functioning. A modified scale. Psychosomatics. 1995; 36: 267275.CrossRefGoogle ScholarPubMed
Harvey, et al. Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am J Psychiatry. 2009; 166: 821827.CrossRefGoogle ScholarPubMed
Heinrichs, et al. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984; 10: 388396.CrossRefGoogle ScholarPubMed
Helldin, et al. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr Res. 2007; 93: 160168.CrossRefGoogle ScholarPubMed
Jaeger, et al. The multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations. Schizophr Bull. 2003; 29: 153168.CrossRefGoogle ScholarPubMed
Kane, et al. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schizophr Res. 2007; 90: 147161.CrossRefGoogle ScholarPubMed
Lambert, et al. Remission in schizophrenia: validity, frequency, predictors, and patients’ perspective 5 years later. Dialogues Clin Neurosci. 2010; 12: 393407.Google ScholarPubMed
Lambert, Naber, Current issues in schizophrenia: overview of patient acceptability, functional capacity and quality of life. CNS Drugs. 2004; 18: 113.CrossRefGoogle ScholarPubMed
Leifker, et al. Validating measures of real-world outcome: the results of the VALERO Expert Survey and RAND Panel. Schizophr Bull. 37 2: 2011 334343.CrossRefGoogle ScholarPubMed
Leucht, et al. On the concept of remission in schizophrenia. Psychopharmacol. 2007; 194: 453461.CrossRefGoogle ScholarPubMed
Liberman, et al. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry. 2002; 14: 256272.CrossRefGoogle Scholar
Llorca, et al. The “Functional Remission of General Schizophrenia” (FROGS) scale: development and validation of a new questionnaire. Schizophr Res. 2009; 113: 218255.CrossRefGoogle ScholarPubMed
Marder, et al. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomised, placebo-controlled trial. Biol Psych. 2007; 62: 13631370.CrossRefGoogle Scholar
Mausbach, et al. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull. 2007; 33: 13641372.CrossRefGoogle ScholarPubMed
Mausbach, et al. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psych Res. 2008; 42: 320327.CrossRefGoogle ScholarPubMed
Morosini, et al. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 2000; 101: 323329.Google ScholarPubMed
Naber, et al. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 10 suppl. 3: 1995 133138.Google ScholarPubMed
Patrick, D.L., Burns, T., Morosini, P., Rothman, M., Gagnon, D.D., Wild, D., Adriaenssen, I.Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance Scale in patients with acute symptoms of schizophrenia. Curr Med Res Opin. 2009; 2: 325338.CrossRefGoogle Scholar
Patterson, et al. UCSD Performance-based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001; 27: 235245.CrossRefGoogle ScholarPubMed
Paykel, et al. Dimensions of social adjustment in depressed women. J Nerv Ment Dis. 1971; 152: 158172.CrossRefGoogle ScholarPubMed
Phelan, et al. The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psych. 1995; 167: 589595.CrossRefGoogle ScholarPubMed
San, et al. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry. 2007; 22: 490498.CrossRefGoogle ScholarPubMed
Simon-Abbadi, et al. Psychometric qualities of the French version of the Heinrichs Quality of Life Rating Scale. Eur Psychiatry. 1999; 14: 386391.CrossRefGoogle ScholarPubMed
Stein, Test.Alternative to mental hospital treatment conceptual model, treatment program and clinical evaluation. Arch Gen Psych. 1980; 37: 409412.CrossRefGoogle ScholarPubMed
Yager, Ehmann, Untangling social function and social cognition: a review of concepts and measurement. Psychiatry. 2006; 69: 4768.CrossRefGoogle Scholar
Young, et al. A comparison between an interview and a self-report method of insight assessment in chronic schizophrenia. Schizophr Res. 2003; 63: 103109.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.